Wen-Cheng Chung

433 citations
13 papers · 350 indexed · h-index 9

Wen-Cheng Chung

13 papers receiving 347 citations

Peers

Wen-Cheng Chung
Comparison fields: 5 of 76
  • Cancer Research 64
  • Oncology 98
  • Molecular Biology 218
  • Physiology 9
  • Sensory Systems 9
Replace Edward J. Sanderlin with:
Edward J. Sanderlin United States
Mona A. Marie United States
Elangovan Thavathiru United States
Chinky Shiu Chen Liu India
Jaekwang Jeong United States
Rachel S. Salamon United States
Kristin Hauff Canada
Rie Kinoshita Japan
Marina Kolesnichenko Germany
Viviane Ponath Germany
Wen-Cheng Chung relative to Edward J. Sanderlin United States Edward J. Sanderlin's profile →
Citations per field
00.5×1.5×1.9×
Edward J. Sanderlin · 1×
Citations per year

Countries citing papers authored by Wen-Cheng Chung

Since Specialization
Citations

This map shows the geographic impact of Wen-Cheng Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Cheng Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Cheng Chung more than expected).

Fields of papers citing papers by Wen-Cheng Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Cheng Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Cheng Chung. The network helps show where Wen-Cheng Chung may publish in the future.

Co-authorship network

The 18 scholars most cited alongside Wen-Cheng Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wen-Cheng Chung Line = papers co-authored together Wen-Cheng Chung links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20243
2 20237
3 20221
4 202015
5 20193
6 201711
7 201712
8 201557
9 201428
10 200929
11 200877
12 200752
13 200555

About Wen-Cheng Chung

Wen-Cheng Chung is a scholar working on Oncology, Otorhinolaryngology, Hardware and Architecture, Molecular Biology and Cell Biology, having authored 13 papers that have together received 350 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Glycosylation and Glycoproteins Research (2 papers), Epigenetics and DNA Methylation (2 papers), Metastasis and carcinoma case studies (2 papers), TGF-β signaling in diseases (2 papers), Cancer-related Molecular Pathways (2 papers), Advanced Breast Cancer Therapies (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Cancer Research (64 citations), Oncology (98 citations), Molecular Biology (218 citations), Physiology (9 citations) and Sensory Systems (9 citations). Wen-Cheng Chung has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Keli Xu, Seung-Hee Ryu, Ja Seok Koo, John C. Kermode, Seung Wook Kim, Shubing Zhang, Lucio Miele, Sita Aggarwal, Guanming Wu and Sean E. Egan. Their work appears in journals such as Neoplasia, Cancer Research, The Journal of Immunology, Cancer Biology & Therapy and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026